Cargando…
Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway
The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, red...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718610/ https://www.ncbi.nlm.nih.gov/pubmed/34975413 http://dx.doi.org/10.3389/fncel.2021.796635 |
_version_ | 1784624766287609856 |
---|---|
author | Bentea, Eduard De Pauw, Laura Verbruggen, Lise Winfrey, Lila C. Deneyer, Lauren Moore, Cynthia Albertini, Giulia Sato, Hideyo Van Eeckhaut, Ann Meshul, Charles K. Massie, Ann |
author_facet | Bentea, Eduard De Pauw, Laura Verbruggen, Lise Winfrey, Lila C. Deneyer, Lauren Moore, Cynthia Albertini, Giulia Sato, Hideyo Van Eeckhaut, Ann Meshul, Charles K. Massie, Ann |
author_sort | Bentea, Eduard |
collection | PubMed |
description | The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, redox balance, and neuroinflammation. In the current study, we investigated the effect of genetic xCT deletion on lactacystin (LAC)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced degeneration of the nigrostriatal pathway, as models for Parkinson’s disease (PD). Dopaminergic neurons of adult xCT knock-out mice (xCT(–/–)) demonstrated an equal susceptibility to intranigral injection of the proteasome inhibitor LAC, as their wild-type (xCT(+/+)) littermates. Contrary to adult mice, aged xCT(–/–) mice showed a significant decrease in LAC-induced degeneration of nigral dopaminergic neurons, depletion of striatal dopamine (DA) and neuroinflammatory reaction, compared to age-matched xCT(+/+) littermates. Given this age-related protection, we further investigated the sensitivity of aged xCT(–/–) mice to chronic and progressive MPTP treatment. However, in accordance with our previous observations in adult mice (Bentea et al., 2015a), xCT deletion did not confer protection against MPTP-induced nigrostriatal degeneration in aged mice. We observed an increased loss of nigral dopaminergic neurons, but equal striatal DA denervation, in MPTP-treated aged xCT(–/–) mice when compared to age-matched xCT(+/+) littermates. To conclude, we reveal age-related protection against proteasome inhibition-induced nigrostriatal degeneration in xCT(–/–) mice, while xCT deletion failed to protect nigral dopaminergic neurons of aged mice against MPTP-induced toxicity. Our findings thereby provide new insights into the role of system x(c)(–) in mechanisms of dopaminergic cell loss and its interaction with aging. |
format | Online Article Text |
id | pubmed-8718610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87186102022-01-01 Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway Bentea, Eduard De Pauw, Laura Verbruggen, Lise Winfrey, Lila C. Deneyer, Lauren Moore, Cynthia Albertini, Giulia Sato, Hideyo Van Eeckhaut, Ann Meshul, Charles K. Massie, Ann Front Cell Neurosci Cellular Neuroscience The astrocytic cystine/glutamate antiporter system x(c)(–) (with xCT as the specific subunit) imports cystine in exchange for glutamate and has been shown to interact with multiple pathways in the brain that are dysregulated in age-related neurological disorders, including glutamate homeostasis, redox balance, and neuroinflammation. In the current study, we investigated the effect of genetic xCT deletion on lactacystin (LAC)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced degeneration of the nigrostriatal pathway, as models for Parkinson’s disease (PD). Dopaminergic neurons of adult xCT knock-out mice (xCT(–/–)) demonstrated an equal susceptibility to intranigral injection of the proteasome inhibitor LAC, as their wild-type (xCT(+/+)) littermates. Contrary to adult mice, aged xCT(–/–) mice showed a significant decrease in LAC-induced degeneration of nigral dopaminergic neurons, depletion of striatal dopamine (DA) and neuroinflammatory reaction, compared to age-matched xCT(+/+) littermates. Given this age-related protection, we further investigated the sensitivity of aged xCT(–/–) mice to chronic and progressive MPTP treatment. However, in accordance with our previous observations in adult mice (Bentea et al., 2015a), xCT deletion did not confer protection against MPTP-induced nigrostriatal degeneration in aged mice. We observed an increased loss of nigral dopaminergic neurons, but equal striatal DA denervation, in MPTP-treated aged xCT(–/–) mice when compared to age-matched xCT(+/+) littermates. To conclude, we reveal age-related protection against proteasome inhibition-induced nigrostriatal degeneration in xCT(–/–) mice, while xCT deletion failed to protect nigral dopaminergic neurons of aged mice against MPTP-induced toxicity. Our findings thereby provide new insights into the role of system x(c)(–) in mechanisms of dopaminergic cell loss and its interaction with aging. Frontiers Media S.A. 2021-12-17 /pmc/articles/PMC8718610/ /pubmed/34975413 http://dx.doi.org/10.3389/fncel.2021.796635 Text en Copyright © 2021 Bentea, De Pauw, Verbruggen, Winfrey, Deneyer, Moore, Albertini, Sato, Van Eeckhaut, Meshul and Massie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular Neuroscience Bentea, Eduard De Pauw, Laura Verbruggen, Lise Winfrey, Lila C. Deneyer, Lauren Moore, Cynthia Albertini, Giulia Sato, Hideyo Van Eeckhaut, Ann Meshul, Charles K. Massie, Ann Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title | Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title_full | Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title_fullStr | Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title_full_unstemmed | Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title_short | Aged xCT-Deficient Mice Are Less Susceptible for Lactacystin-, but Not 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine-, Induced Degeneration of the Nigrostriatal Pathway |
title_sort | aged xct-deficient mice are less susceptible for lactacystin-, but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-, induced degeneration of the nigrostriatal pathway |
topic | Cellular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718610/ https://www.ncbi.nlm.nih.gov/pubmed/34975413 http://dx.doi.org/10.3389/fncel.2021.796635 |
work_keys_str_mv | AT benteaeduard agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT depauwlaura agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT verbruggenlise agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT winfreylilac agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT deneyerlauren agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT moorecynthia agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT albertinigiulia agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT satohideyo agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT vaneeckhautann agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT meshulcharlesk agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway AT massieann agedxctdeficientmicearelesssusceptibleforlactacystinbutnot1methyl4phenyl1236tetrahydropyridineinduceddegenerationofthenigrostriatalpathway |